• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

台湾首例成人女性支气管内炎症性肌纤维母细胞瘤报告：病例报告。

First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report.

机构信息

Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.

Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.

出版信息

Thorac Cancer. 2021 Oct;12(20):2807-2810. doi: 10.1111/1759-7714.14104. Epub 2021 Sep 14.

DOI:10.1111/1759-7714.14104
PMID:34520108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8520803/
Abstract

An inflammatory myofibroblastic tumor (IMT) of the respiratory system is an uncommon disease. In Taiwan, there is a lack of previous studies on tracheobronchial IMT. The tumor is characterized by overexpression of anaplastic lymphoma receptor tyrosine kinase (ALK)-1. Surgical resection is the standard treatment of choice nowadays.

摘要

呼吸系统的炎性肌纤维母细胞瘤（IMT）是一种罕见疾病。在台湾，此前尚无关于气管支气管 IMT 的研究。该肿瘤的特征是间变性淋巴瘤受体酪氨酸激酶（ALK）-1 的过度表达。目前，手术切除是标准的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/736b/8520803/415f4b6db6e9/TCA-12-2807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/736b/8520803/74edc3fced63/TCA-12-2807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/736b/8520803/415f4b6db6e9/TCA-12-2807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/736b/8520803/74edc3fced63/TCA-12-2807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/736b/8520803/415f4b6db6e9/TCA-12-2807-g001.jpg

相似文献

1
First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report.台湾首例成人女性支气管内炎症性肌纤维母细胞瘤报告：病例报告。
Thorac Cancer. 2021 Oct;12(20):2807-2810. doi: 10.1111/1759-7714.14104. Epub 2021 Sep 14.
2
Surgical management of endobronchial inflammatory myofibroblastic tumors.支气管内炎症性肌纤维母细胞瘤的外科治疗。
Ann Thorac Surg. 2011 Feb;91(2):367-72. doi: 10.1016/j.athoracsur.2010.09.017.
3
Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.含有ETV6-NTRK3融合基因的间变性淋巴瘤激酶阴性子宫炎性肌纤维母细胞瘤：一例报告
J Int Med Res. 2018 Aug;46(8):3498-3503. doi: 10.1177/0300060518780873. Epub 2018 Jun 14.
4
Anaplastic lymphoma receptor tyrosine kinase-negative inflammatory myofibroblastic tumor of triceps brachii: Case report.肱三头肌的无间变淋巴瘤受体酪氨酸激酶阴性炎性肌纤维母细胞瘤：病例报告。
Jt Dis Relat Surg. 2020;31(3):605-609. doi: 10.5606/ehc.2020.74662.
5
Inflammatory Myofibroblastic Tumor (IMT) of the Trachea Excised by Transtracheal Surgery: Case Report.经气管外科手术切除的气管炎性肌纤维母细胞瘤（IMT）：病例报告。
Ear Nose Throat J. 2023 Aug;102(8):511-515. doi: 10.1177/01455613211014076. Epub 2021 May 19.
6
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.ALK 阴性青年肺炎性肌纤维母细胞瘤：分子改变的病例报告及文献复习。
Medicine (Baltimore). 2021 May 21;100(20):e25972. doi: 10.1097/MD.0000000000025972.
7
A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.同时诊断的肺腺癌和支气管内炎症性肌纤维母细胞瘤伴两种不同类型的 ALK 易位 1 例
Cancer Res Treat. 2021 Apr;53(2):601-606. doi: 10.4143/crt.2020.952. Epub 2020 Oct 21.
8
Crizotinib in ALK inflammatory myofibroblastic tumors-Current experience and future perspectives.克唑替尼治疗间变性淋巴瘤激酶炎症性肌纤维母细胞瘤——当前经验与未来展望。
Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26920. Epub 2017 Dec 29.
9
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.来自欧洲癌症研究与治疗组织（EORTC）90101 CREATE试验的克唑替尼治疗晚期不可切除炎性肌纤维母细胞瘤患者的长期疗效更新
Eur J Cancer. 2021 Oct;156:12-23. doi: 10.1016/j.ejca.2021.07.016. Epub 2021 Aug 13.
10
Inflammatory Myofibroblastic Tumor of the Tongue. Report of a Pediatric Case and Review of the Literature.舌部炎性肌纤维母细胞瘤。1例儿科病例报告及文献复习
Fetal Pediatr Pathol. 2018 Apr;37(2):117-125. doi: 10.1080/15513815.2017.1385667. Epub 2018 Jan 16.

本文引用的文献

1
A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy.经支气管镜治疗联合肺叶切除术治疗肺部炎症性肌纤维母细胞瘤 1 例。
J Cardiothorac Surg. 2021 May 26;16(1):144. doi: 10.1186/s13019-021-01528-5.
2
Successful rigid bronchoscopic resection of recurrent pulmonary inflammatory myofibroblastic tumor after complete surgical resection.在完整手术切除后，成功通过硬质支气管镜切除复发性肺炎性肌纤维母细胞瘤。
Proc (Bayl Univ Med Cent). 2019 Jun 10;32(3):408-410. doi: 10.1080/08998280.2019.1612688. eCollection 2019 Jul.
3
Inflammatory Myofibroblastic Tumor of the Lung. A Rare Primary Lung Cancer.
肺炎性肌纤维母细胞瘤。一种罕见的原发性肺癌。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):923-924. doi: 10.1164/rccm.201703-0538IM.
4
Inflammatory Myofibroblastic Tumors: Current Update.炎性肌纤维母细胞瘤：最新进展
Radiol Clin North Am. 2016 May;54(3):553-63. doi: 10.1016/j.rcl.2015.12.005. Epub 2016 Mar 12.
5
Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor.儿童炎性假瘤的解读：聚焦炎性肌纤维母细胞瘤
Pediatr Radiol. 2015 Nov;45(12):1738-52. doi: 10.1007/s00247-015-3360-6. Epub 2015 May 12.
6
Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.具有频繁间变性淋巴瘤激酶（ALK）和ROS1基因融合以及罕见新型RET重排的炎性肌纤维母细胞瘤的分子特征
Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404.
7
Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.炎性肌纤维母细胞瘤：FDG PET/CT 表现与病理对照
Clin Nucl Med. 2014 Feb;39(2):113-21. doi: 10.1097/RLU.0b013e3182952caa.
8
Complete resection of pulmonary inflammatory pseudotumors has excellent long-term prognosis.完整切除肺炎性假瘤具有良好的长期预后。
J Thorac Cardiovasc Surg. 2009 Feb;137(2):435-40. doi: 10.1016/j.jtcvs.2008.07.009. Epub 2008 Sep 19.